We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.00 | 0.56% | 1,799.00 | 1,805.00 | 1,807.00 | 1,807.00 | 1,763.00 | 1,786.00 | 466,727 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 20.78 | 3.99B |
TIDMHIK
RNS Number : 0225P
Hikma Pharmaceuticals Plc
23 May 2018
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------------ a) Name John Castellani --- --------------------- ------------------------------------- 2 Reason for the notification --- ------------------------------------------------------------ a) Position/status Non-Executive Director --- --------------------- ------------------------------------- b) Initial notification Initial notification /Amendment --- --------------------- ------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------ a) Name Hikma Pharmaceuticals PLC --- --------------------- ------------------------------------- b) LEI 549300BNS685UXH4JI75 --- --------------------- ------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------ a) Description Description: Ordinary shares of 10 of the financial pence each (Shares) instrument, ID Code: GB00B0LCW083 type of instrument and identification code --- --------------------- ------------------------------------- b) Nature of Market purchase of 1,000 Ordinary the transaction Shares by Brown Advisory Investment Management Firm for and on behalf of John and Therese Castellani. --- --------------------- ------------------------------------- c) Price(s) and Price(s): GBP13.7695 volume(s) Volume(s): 1,000 --- --------------------- ------------------------------------- d) Aggregated information 1,000 * Volume GBP13,769.50 * Price --- --------------------- ------------------------------------- e) Date of the 22 May 2018 transaction --- --------------------- ------------------------------------- f) Place of the London Stock Exchange (XLON) transaction --- --------------------- -------------------------------------
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGCGDUCBDBGIX
(END) Dow Jones Newswires
May 23, 2018 05:20 ET (09:20 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions